Fios at the 3rd Annual Biomarkers & Precision Medicine Conference in San Diego
- 12th September 2018
- Posted by: Claudine Gabriele
- Categories: Biomarkers, Events
When and where
We’re proud to be sponsors of the co-located 5th Annual Drug Discovery, 3rd Annual Biomarkers & Precision Medicine, and the Advances in Immuno-oncology USA conferences, in San Diego, California.
On October 11 – 12, 2018, we’ll be joining over 250 delegates at the San Diego Convention Centre for two days of talks and networking opportunities spread over a number of different streams.
Our CEO, Dr Sarah Lynagh, will be speaking on Day 1, Stream 1: The Role of Biomarkers in Discovery, Safety and Translational Science. She will also be chairing all of Day 2 Stream 2: Biomarker Clinical Development – Enabling Technologies and Precision Medicine.
Why we’re attending
Fios are involved with projects covering areas such as cardiovascular disease and oncology, as well as the use of high throughput technologies including microarrays and next-generation sequencing (NGS). Our clients actively work in areas including pre-clinical and clinical trials, and various aspects of biomarkers research. As such, we want to stay up-to-date with the developments in drug discovery, precision medicine, and immuno-oncology. We regularly attend conferences covering these areas, all over the world.
Exhibiting
As well as speaking during Day 1 Stream 2: Biomarker Clinical Development & Clinical Trials, Fios will also be exhibiting during the conference. Be sure to drop by our stand and have a chat with us about your bioinformatics needs!
To find out more about the conferences and their streams, visit the conference website.
Leave a Reply
You must be logged in to post a comment.
